Adcock Ingram’s turnover rose 6% to R9.6bn, driven by demand for winter cold and flu medicines. HEPS grew 10%, with the final dividend rising to 275 cents.
High winter product demand lifts Adcock Ingram’s turnover
Original Article by Kabelo Khumalo | Business Day | 23 August 2024
Adcock Ingram's turnover rose 6% to R9.6bn, driven by demand for winter cold and flu medicines. HEPS grew 10%, with the final dividend rising to 275 cents.
More Posts
Mpox Cases in SA Rise as Local Transmission Accelerates
Mpox cases in South Africa are rising, mainly in the Western Cape. What the surge means for the healthcare industry.
Read more...
NHLS Scrambles as Pathology Services Funding Runs Dry
The NHLS is scrambling for new providers after funds for haematology pathology services ran dry, amid an R11.3bn provincial debt
Read more...
Momentum Group Posts Record Earnings
Momentum Group has posted record earnings, with normalised headline earnings up 13% to R7.06bn – beating its R7bn Impact target a year early.
Read more...